NHS Cancer Plan

Oncology

The NHS Cancer Plan has commissioned the Royal College of Radiologists with a formal review of opportunities to modernise Multi-Disciplinary Teams.

R&D

Whole-genome sequencing provides an unbiased and complete view of the human genome and enables the discovery of genetic variation.

News

argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2bn acquisition of Forte, is moving into phase 3 testing for coeliac disease.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.